A sharper eye on the heart: new blood test aims to spot heart attacks faster

NCT ID NCT05853042

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial evaluates a new high-sensitivity blood test (Mindray hs-cTnI) for diagnosing heart attacks in people arriving at the emergency room with symptoms like chest pain. Researchers will compare the test's accuracy against an existing approved test, using blood samples taken at arrival and two hours later. The goal is to see if the new test can reliably rule out or confirm a heart attack, potentially speeding up care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
high-sensitivity cardiac troponin I blood test (Mindray hs-cTnI assay)
What this could lead to
If successful, this could provide a faster, more accurate way to diagnose heart attacks in the emergency room, potentially reducing unnecessary hospital stays.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The test may not prove more effective than existing assays, and results may vary across different patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hennepin Healthcare Research Institute / Hennepin County Medical Center

    Minneapolis, Minnesota, 55404, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.